Hammerman M, Blomgran P, Ramstedt S, Aspenberg P. COX-2 inhibition impairs mechanical stimulation of early tendon healing in rats by reducing the response to microdamage. J Appl Physiol 119: 534 -540, 2015. First published July 9, 2015; doi:10.1152/japplphysiol.00239.2015.-Early tendon healing can be stimulated by mechanical loading and inhibited by cyclooxygenase (COX) inhibitors (nonsteroidal anti-inflammatory drugs). Therefore, we investigated if impairment of tendon healing by a COX-2 inhibitor (parecoxib) is related to loading. Because loading might infer microdamage, which also stimulates healing, we also investigated if this effect is inhibited by parecoxib. The Achilles tendon was transected in 114 rats. Three degrees of loading were used: full loading, partial unloading, and unloading (no unloading, Botox injections in the plantar flexor muscles, or Botox in combination with tail suspension). For each loading condition, the rats received either parecoxib or saline. In a second experiment, rats were unloaded with Botox, and the tendon was subjected to microdamage by needling combined with either saline or parecoxib. Mechanical testing day 7 showed that there was a significant interaction between loading and parecoxib for peak force at failure (P Ͻ 0.01). However, logarithmic values showed no significant interaction, meaning that we could not exclude that the inhibitory effect of parecoxib was proportionate to the degree of loading. Microbleeding was common in the healing tissue, suggesting that loading caused microdamage. Needling increased peak force at failure (P Ͻ 0.01), and this effect of microdamage was almost abolished by parecoxib (P Ͻ 0.01). Taken together, this suggests that COX-2 inhibition impairs the positive effects of mechanical loading during tendon healing, mainly by reducing the response to microdamage.
effects of NSAIDs in the healing of tendon injuries, because negative as well as positive effects may occur in patients.
The ability of a tissue to perceive mechanical loading is termed mechanotransduction. This ability is usually ascribed to most cells of mesenchymal origin, who use it to adapt and optimize themselves and the surrounding matrix to mechanical demands. Mechanical loading improves tendon healing in many animal models (2, 3, (8) (9) (10) (11) (12) 18) , and it has recently been shown to be beneficial for patients recovering from Achilles tendon rupture (19) . The underlying mechanisms are still unclear, but COX enzymes and prostaglandins seem to play an important role. PGE 2 increases in tendons and tenocytes subjected to mechanical loading (1, 15, 24) , and this increase can be abolished by a COX inhibitor (1, 15) . Mechanical loading also increases collagen synthesis in tendons (5) , which can also be inhibited by a COX inhibitor (5, 10) . Furthermore, PGE synthase, which is an enzyme involved in PGE 2 production, is upregulated after loading in healing rat tendons (9) . This suggests that mechanical loading affects PGE 2 production, which might play an important role in tendon remodeling and healing. In patients, administration of NSAIDs might attenuate the positive effect that mechanical stimulation has on tendon healing.
As mechanical stimulation is important for tendon healing, immobilization impairs the healing process and makes the healing tendon weaker (3, 18) . In a previous study, we reduced the mechanical stimulation during tendon healing by paralyzing the plantar flexor muscles with Botox (3). This reduced the peak force at failure to 34% of that of fully loaded tendons. However, by reducing mechanical stimulation even further, via paralysis of the plantar flexor muscles together with tail suspension, the peak force at failure was reduced to only 19% of fully loaded tendons. These results indicate that even weak loading is important for tendon healing. In contrast, the crosssectional area was reduced by 50% with Botox treatment, but there was no further reduction when tail suspension was added. This suggests that strong loading increases callus size, whereas weak loading mainly affects tissue quality.
As the first tissue after tendon rupture is mechanically weak, strong loading during early tendon healing can cause local damage. This can lead to bleedings in the healing tissue and an increase in callus size via increased inflammation (8) . Microdamage might be a stimulator of tendon healing in itself. Indeed, microdamage by needling of the healing tendon, in absence of loading, increased tendon callus size and peak force at failure with a striking similarity between the gene expression response to mechanical loading (14) . Moreover, PGE synthase was upregulated by either loading or microdamage during early tendon healing (10, 14) . These results suggest that the response to strong loading during early tendon healing can, at least in part, be a response to microdamage, leading to increased inflammation.
During remodeling after tendon rupture, new collagen fibrils in the tendon callus are aligned to the direction of mechanical stress. The required directional information can only be provided by mechanical loading. In consequence, loading has been thought to be important mainly for the remodeling phase of healing. However, recent data have shown a stimulatory effect of loading also during the inflammatory phase of healing, suggesting that other mechanisms may play a role (8) . One possible mechanism could be stimulation of the inflammatory response to trauma.
Taken together, mechanical loading stimulates tendon healing and increases PGE 2 levels. The increase in PGE 2 might be important for the stimulatory effects of loading during early tendon healing. Therefore, it is possible that the detrimental effect of COX-2 inhibition could be caused by a decreased ability to respond to mechanical stimulation. On the other hand, previous studies have shown that, also microdamage, in the absence of loading, can stimulate early tendon healing and affect PGE 2 production. We, therefore, investigated if the impairment of early tendon healing by a COX-2 inhibitor (parecoxib) is related to the degree of loading, or to microdamage.
In a first experiment, we hypothesized that the negative effects of COX-2 inhibition would only appear when loading is applied. The findings led to a second experiment with the hypothesis that COX-2 inhibition would inhibit the response to microdamage also in the absence of loading.
MATERIAL AND METHODS

Study Design
We first studied if the effect of parecoxib treatment was different between three different loading regimes, analyzing six groups (parecoxib and saline for each loading condition). Because full loading might lead to microdamage, we then performed a second separate experiment, to see if the effect of parecoxib treatment was different after microdamage (Fig. 1) .
In all, 114 female Sprague-Dawley rats were used (12-13 wk old): 78 for loading and 36 for microdamage. All allocations of rats to different treatment groups were randomized by means of a lottery, and the investigator was blinded during surgery and mechanical evaluation. The right Achilles tendon was transected in all rats and allowed to heal spontaneously. The day of transection is referred to as day 0.
In the loading experiment, three degrees of loading were used: unloading, partial unloading, and full loading (normal cage activity). Partial unloading was achieved by intramuscular injection of Botox 4 days before tendon transection, and unloading was achieved by combining Botox with tail suspension. All tail suspended rats were suspended on day 1. For each loading condition, the rats received a daily dose of parecoxib or saline on days 0 -4. The rats were euthanized on day 7, and the healing tendons were evaluated by mechanical testing. There were 12-15 rats in each group.
In the microdamage experiment, all rats were unloaded with Botox and allocated to three groups: needling days 2-5 combined with parecoxib days 0 -5; needling with saline injections days 0 -5; and no needling. The rats were euthanized on day 8, and the healing tendons were evaluated by mechanical testing. There were 12 rats in each group.
All experiments were approved by the Regional Ethics Committee for animal experiments in Linköping and adhered to the institutional guidelines for care and treatment of laboratory animals. The rats were housed two per cage, except the tail suspended rats, which were housed one per cage. All rats were given food and water ad libitum.
Surgery
All rats were anesthetized with isoflurane gas (Forene, Abbot Scandinavia, Solna, Sweden) and given antibiotics (25 mg/kg, oxytetracycline, Engemycin; Intervet, Boxmeer, The Netherlands) preoperatively. They were also given analgesics (0.045 mg/kg buprenorphine, Temgesic; Schering-Plough, Brussels, Belgium) preoperatively and regularly until 48 h after surgery. The surgery was performed under aseptic conditions. The skin over the right Achilles tendon was shaved and washed with chlorhexidine ethanol. A transverse skin incision was made lateral to the Achilles tendon, and the tendon complex was exposed. The plantaris tendon was removed to avoid interference during material testing. The Achilles tendon was transversely transected, and the tendon was left to heal spontaneously without any sutures. The skin was closed by two stitches.
Unloading
Botox. Ninety rats were given intramuscular Botox injections to induce plantar flexor muscle paralysis 4 days before tendon transection. The rats were anesthetized with isoflurane gas, and the right hindlimb was shaved. Botulinum toxin (Botox, Allergan, Irvine, CA) was injected into the gastrocnemius lateralis and medianus and the soleus muscles at a dose of 1 U/muscle, giving a total dose of 3 U/animal and a total volume of 0.06 ml. The animals were thereafter allowed free cage activity for 4 days before tendon transection, to allow the full effect of Botox to develop.
Tail suspension. One day after surgery, the hindlimbs of 30 rats were unloaded by tail suspension. All of these rats had received Botox. The tail suspension was carried out in special cages with an overhead system that allowed the rats to rotate and move in all directions using their forelimbs, whereas the hindlimbs were lifted just above the cage floor. The rats had been acclimatized to the suspension cages before surgery. For suspension, an adhesive tape was attached to the rat's tail. The tape was connected to the overhead system by a fish-line swivel and a fish line. The tail suspension technique is described in more detail elsewhere (17) .
Drug Administration
All animals in the parecoxib groups were administered parecoxib (Dynastat, Pfizer, Belgium) 6.4 mg/kg body wt subcutaneously once a day. The first injection was given immediately before surgery. Rats in the loading experiment received parecoxib on days 0 -4, and rats in the microdamage experiment received parecoxib on days 0 -5. The animals in the placebo groups were given a corresponding volume of saline subcutaneously at the same time points. The dose of parecoxib injected corresponds to the recommended postoperative dose per body weight for humans, multiplied by 4 to compensate for the about four times higher basal metabolic rate in rats (23) .
Microdamage
Twenty-four rats in the microdamage experiment were subjected to needling of their tendon callus. They were first anesthetized with isoflurane and then given four skin penetrations using an insulin needle (0.25 mm in diameter, size 31 G) from the lateral, medial, proximal, and distal side of the callus. After the skin was penetrated, the needle was forced into the callus tissue 5 times in different directions, resulting in a total of 20 punctures into the callus. The needling was performed once a day on days 2-5.
Mechanical Evaluation
All rats were euthanized with carbon dioxide. The right Achilles tendon together with the calcaneal bone and the gastrocnemius and soleus muscle complex was dissected free and harvested. Sagittal and transverse diameter of the midpart of the callus tissue was measured with a slide caliper, and cross-sectional area was calculated by assuming an elliptical geometry [(sagittal d ϫ transverse d ϫ )/4]. The distance d between the old tendon stumps (the gap distance) was measured as seen through the partly transparent callus tissue. The muscles were carefully scraped off from the tendon fibers, and the tendon fibers were fixed in a metal clamp by fine sandpaper. The distance between the metal clamp and the calcaneal bone was measured as the length of the specimen. The bone was fixed in a custom-made clamp at 30°d orsiflexion relative to the direction of traction in the material testing machine (100R, DDL, Eden Prairie, MN). The machine pulled at a constant speed of 0.1 mm/s until failure. Location of failure was recorded for each sample. Peak force at failure (N), stiffness (N/mm), and energy uptake (Nmm) were calculated by the software of the testing machine. The investigator marked a linear portion of the elastic phase of the curve for stiffness calculation. Peak stress and an estimate of Young's modulus were calculated afterwards, assuming an elliptic cylindrical shape and homogenous mechanical properties. The displacement was expressed as a fraction of the starting length of the sample. All measurements and calculations were carried out by a blinded investigator.
Statistical Analysis
We used IBM SPSS, version 22. Normal distribution was confirmed by Shapiro-Wilks test. The loading experiment was analyzed by two-way ANOVA, using loading and parecoxib as independent variables and peak force at failure as primary outcome variable. The primary hypothesis was that there would be a dependence between the effects of loading and parecoxib on force at failure. This was tested after ln-transformation of the force values, to test the null hypothesis that there was a proportionate dependence (i.e., that parecoxib removed a fixed proportion of the mechanical loading effect). P values Յ 0.05 were regarded as significant. Thereafter, post hoc tests were performed, comparing the three saline and parecoxib groups for each loading condition separately using Student's t-test. Here the cutoff for significance was set at P Յ 0.017 (Bonferroni's correction for 3 comparisons). Differences between group means are presented with 95% confidence intervals. The microdamage experiment was analyzed with one-way ANOVA followed post hoc test with Bonferroni's adjustment of P values (significance level: Յ0.05) using peak force at failure as primary outcome variable. The important comparison was between needling with and without parecoxib.
RESULTS
Mechanical Loading Experiment
Loading. Loading increased peak force at failure of the healing tendon (P Ͻ 0.001; Fig. 2 and Table 1 ). Compared with unloading, partial unloading increased peak force at failure by 68%, and full loading by 346% ( Table 2) . The cross-sectional area of the healing tendon behaved differently: there was only 4% difference between unloading and partial unloading, but full loading increased the cross-sectional area by 32% compared with unloading (Fig. 2) . All mechanical variables showed a statistically significant effect of loading (Table 1) .
Parecoxib. Parecoxib reduced peak force at failure, compared with saline (P Ͻ 0.001; Fig. 2 and Table 1 ). The decrease was 3% in the unloaded group, 15% in the partially unloaded group, and 31% in the fully loaded group ( Table 2) . The cross-sectional area was reduced by 10% in the unloaded group, 8% in the partially unloaded group, and by 31% in the fully loaded group (Fig. 2) . There was also a significant reduction in cross-sectional area, stiffness, and energy uptake (Table 1) .
Interaction between loading and parecoxib. There was a statistically significant interaction between loading and parecoxib for peak force at failure (P ϭ 0.001) and energy uptake, meaning that the effect of parecoxib increased with increased loading (Table 1) . Analysis of logarithmic values showed no significant interaction (P ϭ 0.138). In other words, this analysis could not exclude that parecoxib reduced the peak force at failure by a fixed percentage, independent of the degree of Fig. 2 . Loading experiment. Peak force at failure and cross-sectional area 7 days after tendon transection is shown. The unloading groups received Botox before tendon transection and were tail suspended, the partial unloading groups received Botox only, and the full loading groups had normal cage activity. The parecoxib and saline groups received daily injections during the first 5 days after transection. N ϭ 11-13 rats in each group. *P value Ͻ 0.017. loading. However, the post hoc analysis showed a significant effect of parecoxib only in the fully loaded tendons (P ϭ 0.003; Table 3 ). Without full loading, the reduction with parecoxib was not significant (P ϭ 0.037 in the partially unloaded tendons and P ϭ 0.858 in the unloaded tendons; significance level 0.017).
Microdamage Experiment
Microdamage. Repeated microdamage by needling for 4 consecutive days increased peak force at failure by 46% (P ϭ 0.001) compared with controls that underwent no needling (Fig. 3 , Table 2 and Table 4 ). Microdamage also influenced the cross-sectional area (79% increase), energy uptake (149% increase), estimate of Young's modulus (47% decrease), and displacement at rupture (64% increase).
Interaction between microdamage and parecoxib. Compared with the needling group injected with saline, parecoxib reduced peak force at failure by 31% (P ϭ 0.002), the crosssectional area by 31%, and energy uptake by 49% (Fig. 3 , Tables 2 and 4 ). This means that parecoxib completely eliminated the stimulatory effect of needling on peak force at failure, so that needling with parecoxib became similar to no needling (1% difference). Parecoxib also reduced the stimulatory effect of needling on cross-sectional area by 76% (24% difference between needling and no needling remained).
Excluded Animals
Ten rats were excluded from the study: four rats because of problems from the surgical wound; two rats because they had fallen down from the tail suspension device; one rat because of a swollen foot before surgery; one rat because it got a bruise from the needling so the needling procedure could not be carried on; one rat because of unexplainable death on day 3; and one rat because the plantaris tendon had not been removed during surgery. There was no case of slippage or failure at the clamp when measuring the tendon tissue in the material testing machine.
DISCUSSION
The stimulatory effect of both loading and needling during early tendon healing was reduced by COX-2 inhibition. The strongest reduction was seen when the healing tendon was stimulated by needling, where COX-2 inhibition seemed to completely eliminate the stimulatory effect.
The effect of COX-2 inhibition was stronger with more loading. However, we were unable to show that the proportionate effect of COX-2 inhibition changed, as the interaction between ln-transformed data was not statistically significant. Values are means Ϯ SD; N, no. of rats. P values are from two-way ANOVA, using loading and parecoxib as independent variables. The unloading groups received Botox before tendon transection and were tail suspended, the partial unloading groups received Botox only, and the full loading groups had normal cage activity. The parecoxib and saline groups received daily injections during the first 5 days after transection. *Displacement at rupture is expressed as a fraction of the starting length of the sample. Values are P values from Student's t-test, with significance cutoff at P ϭ 0.017 (Bonferroni's correction); N, no. of rats. The unloading groups received Botox before tendon transection and were tail suspended, the partial unloading groups received Botox only, and the full loading groups had normal cage activity. The parecoxib and saline groups received daily injections during the first 5 days after transection.
Therefore, it cannot be excluded that COX-2 inhibition reduces the peak force at failure by a fixed percentage. This means that we could not confirm our original hypothesis that COX-2 inhibition interferes with mechanotransduction during loading. However, the strongest effect of COX-2 inhibition was seen in the group where the rats had been fully loaded. In the post hoc analysis, the highly significant effect of COX-2 inhibition in the full loading group contrasts to the lack of statistical significance in the unloaded group. This suggests that COX-2 inhibition impairs the positive effects of loading during tendon healing, although not necessarily by interfering with mechanotransduction.
In our rat model, mechanical loading might stimulate early tendon healing through both mechanotransduction and a response to microdamage (8) . Microdamage in the healing tissue increases bleeding, swelling, and inflammation, leading to an increase in cross-sectional area of the callus. When loading was increased from unloading to partial unloading, the peak force at failure of the healing tendon increased, but not the cross-sectional area. However, a further increase in loading to free cage activity increased the cross-sectional area by around 30%, compared with partially unloaded and unloaded rats. Similarly, needling increased the cross-sectional area by 79%, but had small effects on tissue quality. Therefore, we believe that the trauma component of loading occurred mainly in the fully loaded group. COX-2 inhibition reduced the increase in cross-sectional area in response to microdamage by 76%, and in the loading experiment the strongest reduction was seen in the fully loaded group. Taken together, these results suggest that COX-2 inhibition inhibits the positive effects of mechanical loading mainly by reducing the response to microdamage.
Tissue quality, estimated from peak stress and estimate of Young's modulus, improved with loading, but was largely uninfluenced by COX-2 inhibition. As tissue quality partly reflects tissue organization, and this conceivably is a result of mechanotransduction, the absent effect of COX-2 inhibition again suggests that it is not involved in mechanotransduction to an important degree in this context. Another possibility would be that COX-2 inhibition decreases the production on nontensile-bearing proteins.
Positive effects of loading during tendon healing have been shown in many studies (2, 3, 8 -12, 18, 19) . The underlying mechanisms are still unclear, although COX enzymes and prostaglandins seem to play an important role and might have a stimulatory effect on tendon remodeling and healing. Our results confirm that COX-2 activity in response to loading is important also during early tendon healing, but not necessarily for the effect of mechanotransduction. Previous studies has shown that PGE synthase is upregulated by needling in early healing tendons (14) , suggesting that PGE 2 plays a role also for the stimulatory effects of microdamage. The reason why COX-2 inhibition seemed to have a stronger effect on the Fig. 3 . Microdamage experiment. Peak force at failure and cross-sectional area 8 days after tendon transection is shown. All groups received Botox. The parecoxib and saline group underwent microdamage by needling on days 2-5 after transection and received daily subcutaneous injections of parecoxib or saline during the first 6 days after transection. N ϭ 10 -12 rats in each group. *P value Ͻ 0.01. Values are means Ϯ SD; N, no. of rats. P values are from one-way ANOVA and Bonferroni post hoc test. All groups received Botox. The parecoxib and saline groups underwent microdamage by needling on days 2-5 after transection and received daily subcutaneous injections of parecoxib or saline during the first 6 days after transection. *Displacement at rupture is expressed as a fraction of the starting length of the sample.
response to microdamage compared with loading in this experiment might relate to how PGE 2 production responds to loading vs. microdamage. In the same model as the present study, a short episode of full loading upregulated the expression of PGE synthase 1.7-fold (9) . In contrast, the upregulation by needling was 11-fold (14) . This difference could explain why COX-2 inhibition had a stronger effect on microdamage compared with loading.
We have also studied the groups, full loading, Botox, and Botox with needling, by histology in 21 rats as a follow-up to the mechanical data reported here. The histological observations showed differences between the three groups regarding the organization of the tissue (Fig. 4) . In the Botox tendons and the Botox tendons stimulated by needling, the tendon callus was interspersed with adipocytes. In contrast, the fully loaded tendons contained just a few adipocytes within the healing callus. Thus it seems that full loading can block adipocyte formation and stimulate fibroblast or tenocyte differentiation and matrix production. Microbleedings were detected as extravasated erythrocytes and by Preussinan blue staining in all three groups, not only in the tendons subjected to needling. As shown in the loading experiment, Botox only partially unloads the tendon, suggesting that also partial unloading can create microbleedings in the healing tissue. Obviously, microdamage is common in this model, but differences between groups need to be investigated with a sample size sufficient for statistical analysis.
Taken together, our result suggests that the most important effect of COX-2 inhibition during early tendon healing is involved in the response to microdamage, rather than mechanotransduction. From a clinical perspective, the negative effects of NSAIDs, seen in animal experiments, might not be detrimental for patients, as they usually protect their injured tendons from injurious loading during the first period after rupture, when NSAIDs normally are used. Indeed, one rabbit study has shown that COX inhibition during tendon healing had no effect on healing when the tendon was immobilized (4) .
There are limitations to this study. First of all, differences between rats and humans can impair generalization. The most important difference might be size, and this has many effects. For example, in a small animal, the metabolic rate is higher; diffusion distances are shorter, leading to different concentrations of nutrients and signaling substances; also the relation between the injured volume and the area of the interface to the surrounding uninjured tissue is different. Moreover, our primary outcome was peak force at failure, and we do not know if that is a relevant parameter from a patient's point of view. We do not even know if the risk of rerupture, an important complication of healing, is related to strength measured as peak force at failure. Furthermore, our study only investigated the effects of parecoxib for a short time period in the early phase of tendon healing, i.e., 1 wk after injury. Previous studies have shown that COX-2 inhibition can improve tendon healing during later phases (22) . Therefore, we do not know how the effects would be if the administration of parecoxib would be prolonged, or if the treatment starts in a later phase of healing. Additionally, the dosage of parecoxib administrated to the rats might not correspond to the concentration seen in humans, although we tried to compensate for the rats' higher metabolic rate by multiplying the recommended human dose by 4. Finally, it is difficult to know if it is possible to compare the different loading conditions used in our rats and the different loading conditions that occur in patients. However, we believe that loading during rat cage activity after injury is quite different from human behavior, because rats have evolved to avoid predation. Predators prefer weak prey, and rats therefore are forced to avoid showing weakness by limping, and thus do not protect injured limbs as humans do. Furthermore, we know from unpublished data that patients with an Achilles tendon rupture in a cast or a brace load their tendon very little or not Fig. 4 . Histology of the healing tendon. Dashed lines indicate the interface between healing tissue and the transected tendon stump. A: loaded tendon (control; magnification, ϫ4). B: unloaded tendon (magnification, ϫ4). C: unloaded tendon subjected to needling (magnification, ϫ4). D: a small amount of extravasated erythrocytes (red; magnification, ϫ40). E: a large amount of extravasated erythrocytes (red; magnification, ϫ40). F: intracellular iron (blue) in presumed macrophages, indicating old bleeding (magnification, ϫ40).
at all. Therefore, we combined the two different unloading techniques, Botox and tail suspension, to reduce loading as much as possible. By combining these two techniques, the peak force at failure was even further reduced compared with Botox or tail suspension alone (3). To visualize our results, we used unloading as the reference and compared it to partial unloading and loading, because we believe that unloaded rat tendons are more similar to the human situation.
In conclusion, it appears that NSAIDs impair the stimulatory effects of loading and microdamage on early tendon healing. The strongest effect was seen when tendon healing was stimulated by microdamage, suggesting that NSAIDs mainly inhibit the positive effects of microdamage and associated inflammation.
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